Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UCFC
2101
DELISTED
United Community Financial Corp
UCFC
| $1.07M | ﹤0.01% |
92,100
+1,500
| +2% | +$16.7K |
|
2102
ANI Pharmaceuticals
ANIP
$1.7B
| $1.07M | ﹤0.01% |
17,400
+400
| +2% | +$26.5K |
|
2103
Cooper-Standard Automotive
CPS
$487M
| $1.07M | ﹤0.01% |
32,300
-600
| -2% | -$19.4K |
|
2104
Green Plains
GPRE
$1.07B
| $1.07M | ﹤0.01% |
69,400
-4,400
| -6% | -$59.9K |
|
|
ECHO
2105
DELISTED
Echo Global Logistics, Inc.
ECHO
| $1.07M | ﹤0.01% |
51,700
| – | – |
|
|
SRDX
2106
DELISTED
Surmodics
SRDX
| $1.07M | ﹤0.01% |
25,800
+800
| +3% | +$33.7K |
|
2107
Select Water Solutions
WTTR
$2.73B
| $1.07M | ﹤0.01% |
115,100
+3,400
| +3% | +$27.5K |
|
2108
AdvanSix
ASIX
$436M
| $1.06M | ﹤0.01% |
53,200
| – | – |
|
2109
Ducommun
DCO
$3.06B
| $1.06M | ﹤0.01% |
21,000
+800
| +4% | +$36.8K |
|
2110
Bank of Marin Bancorp
BMRC
$464M
| $1.06M | ﹤0.01% |
23,500
+600
| +3% | +$26.5K |
|
2111
Anterix
ATEX
$1.65B
| $1.06M | ﹤0.01% |
24,450
+900
| +4% | +$36.7K |
|
2112
OneSpan
OSPN
$600M
| $1.06M | ﹤0.01% |
61,700
+1,800
| +3% | +$30.6K |
|
2113
Collegium Pharmaceutical
COLL
$854M
| $1.05M | ﹤0.01% |
51,200
+1,600
| +3% | +$26.7K |
|
2114
GameStop
GME
$8.3B
| $1.05M | ﹤0.01% |
691,128
+21,200
| +3% | +$31.1K |
|
2115
Travere Therapeutics
TVTX
$5.82B
| $1.05M | ﹤0.01% |
74,000
+4,600
| +7% | +$58.8K |
|
|
WMC
2116
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $1.05M | ﹤0.01% |
10,163
+280
| +3% | +$28.4K |
|
2117
W&T Offshore
WTI
$565M
| $1.05M | ﹤0.01% |
188,500
+5,300
| +3% | +$23.6K |
|
2118
Goosehead Insurance
GSHD
$2.28B
| $1.05M | ﹤0.01% |
+24,700
| New | +$1.09M |
|
|
JAG
2119
DELISTED
Jagged Peak Energy Inc.
JAG
| $1.04M | ﹤0.01% |
122,600
+3,600
| +3% | +$26.3K |
|
2120
GoPro
GPRO
$111M
| $1.04M | ﹤0.01% |
239,700
+11,200
| +5% | +$46.5K |
|
|
HT
2121
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.04M | ﹤0.01% |
71,375
+2,100
| +3% | +$29.8K |
|
|
QADA
2122
DELISTED
QAD Inc.
QADA
| $1.04M | ﹤0.01% |
20,400
+600
| +3% | +$28.7K |
|
2123
MYR Group
MYRG
$5.26B
| $1.04M | ﹤0.01% |
31,800
+1,000
| +3% | +$33K |
|
|
STFC
2124
DELISTED
State Auto Financial Corp
STFC
| $1.04M | ﹤0.01% |
33,400
+1,100
| +3% | +$35.4K |
|
2125
Mercantile Bank Corp
MBWM
$1.05B
| $1.03M | ﹤0.01% |
28,300
+600
| +2% | +$21.1K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.